Mast cell tumors in dogs arise from a combination of genetic mutations, breed-related inherited risk, and likely some environmental triggers that remain poorly understood. They are the most common skin cancer in dogs, making up 16 to 21% of all canine skin tumors. No single cause has been identified, but the strongest evidence points to specific gene mutations and hereditary predisposition in certain breeds.
The Gene Mutation Behind Most Cases
The most well-studied driver of mast cell tumors is a mutation in a gene called c-kit. This gene normally produces a protein that tells cells when to grow and when to stop. When c-kit mutates, it essentially gets stuck in the “on” position, signaling the cell to keep dividing without the usual brakes. The result is uncontrolled mast cell growth that forms a tumor.
These mutations show up in a significant share of cases. In skin-based (cutaneous) mast cell tumors, c-kit mutations have been found in up to 45% of cases. The mutations most commonly occur in two specific regions of the gene, called exon 11 (found in roughly 20 to 45% of cutaneous tumors) and exon 8 (found in up to 33%). Tumors that sit just beneath the skin (subcutaneous tumors) carry these mutations less often, at around 6% and 11% respectively. Tumors with c-kit mutations tend to behave more aggressively and are more likely to respond to targeted drug therapies, so your vet may test for this mutation after diagnosis.
Breeds With the Highest Risk
Certain breeds develop mast cell tumors at dramatically higher rates, which tells researchers that inherited genetics play a major role beyond just the c-kit mutation. A large study comparing tumor types across breeds found six breeds with the strongest predisposition:
- Shar-Peis: roughly 6 times more likely to develop a mast cell tumor than other breeds
- Boxers: about 5 times more likely
- American Staffordshire Terriers: about 2.7 times more likely
- Labrador Retrievers: about 2.4 times more likely
- French Bulldogs: about 2 times more likely
- Golden Retrievers: about 1.7 times more likely
The Shar-Pei’s six-fold increase is striking and suggests that this breed carries genetic traits beyond c-kit that make mast cells more prone to becoming malignant. Boxers develop mast cell tumors frequently but often get lower-grade versions with a better prognosis. If your dog is one of these breeds, it doesn’t mean a tumor is inevitable, but it does mean lumps and bumps on the skin are worth having checked promptly.
Age and Sex Patterns
Most dogs are diagnosed with mast cell tumors in middle age, typically between 8 and 10 years old. However, these tumors can appear at any age. A multi-institutional study of dogs diagnosed before 12 months of age found a median age at diagnosis of just 9 months, confirming that even puppies are not immune. Research has not found a meaningful difference in risk between males and females, and studies looking for estrogen receptors on mast cell tumors found no clear hormonal link. Spay or neuter status does not appear to be a significant factor in whether a dog develops this type of cancer.
The Role of Inflammation
There is an interesting relationship between chronic skin inflammation and mast cell tumors, though whether inflammation causes the tumors or simply accompanies them is still being sorted out. Mast cells are part of the immune system’s first-response team. They live in skin and connective tissue, ready to release chemicals like histamine when triggered by allergens, wounds, or irritants. Research has shown that mast cell tumors contain heavy infiltrates of inflammatory cells, including eosinophils (allergy-related immune cells), and the surrounding skin often shows signs of an immediate hypersensitivity reaction, similar to an allergic response.
This has led some researchers to propose that repeated cycles of inflammation and mast cell activation could create conditions where a mast cell is more likely to accumulate mutations and turn malignant. Dogs with chronic skin allergies or irritation may have mast cells that are constantly dividing and releasing inflammatory chemicals, which could theoretically raise the odds. But this remains a plausible mechanism rather than a proven cause. No specific allergen or skin condition has been definitively linked to tumor development.
Environmental Factors Remain Unclear
Unlike some other cancers, mast cell tumors in dogs have not been convincingly tied to specific environmental exposures like pesticides, household chemicals, or UV radiation. Researchers have looked for these connections, but no strong associations have emerged. This is partly because the genetic component is so dominant, especially in predisposed breeds, that it may overshadow any environmental contribution. It is also difficult to study because dogs in the same household share both genetics (if they are the same breed) and environmental exposures, making it hard to separate the two.
How Normal Mast Cells Become Tumors
In a healthy dog, mast cells mature in the bone marrow and travel to tissues throughout the body, especially the skin, lungs, and digestive tract. They sit quietly until activated by an immune trigger, then release granules packed with histamine and other chemicals. This is useful in small doses for fighting parasites and healing wounds.
The transformation into a tumor happens when a mast cell acquires mutations (like those in c-kit) that disable its normal growth controls. Instead of sitting quietly and responding only when needed, the mutated cell begins replicating on its own. These abnormal cells still contain granules, which is why mast cell tumors can cause unusual symptoms. When the tumor is touched or disturbed, the cells release their contents, causing localized redness, swelling, and raised bumps around the mass. Vets call this Darier’s sign, and it is one of the hallmarks that helps identify a suspected mast cell tumor during a physical exam. In more advanced cases, widespread granule release can cause stomach ulcers, changes in blood pressure, and systemic allergic-type reactions.
Why Grading Matters More Than Cause
Once a mast cell tumor is found, the question that matters most for your dog’s outcome is not what caused it but how aggressive it is. Vets use grading systems to determine this. The older Patnaik system divides tumors into three grades: grade 1 tumors are well-differentiated and confined to the upper skin layers, grade 2 tumors extend deeper into surrounding tissue, and grade 3 tumors are poorly differentiated and infiltrate deeply. The newer Kiupel system simplifies this into just two categories, low grade and high grade, based on how rapidly cells are dividing and how abnormal they look under a microscope.
Low-grade tumors that are caught early and removed with clean surgical margins carry an excellent prognosis. High-grade tumors are more likely to have already spread at the time of diagnosis and typically require additional treatment. Knowing whether a tumor carries a c-kit mutation also helps guide treatment decisions, since dogs with that mutation may benefit from drugs specifically designed to block the overactive growth signal.